🔗 Permalink

Inventor profile of:

Raymond John Andersen

City:

Vancouver

Country:

Canada

Published Applications:

Last publication date:

2025-03-27

Top Assignees for applications by Raymond John Andersen

The entities that hold a legal rights for patent applications filed by inventor Andersen Raymond John:

The University of British Columbia 9 Vancouver, Canada
British Columbia Cancer Agency Branch 8 Vancouver, Canada
PROVINCIAL HEALTH SERVICES AUTHORITY 3 Vancouver, Canada
ESSA Pharma, Inc. 3 Vancouver, Canada
British Columbia Cancer Agency Branch 2 , Canada
BRITISH COLUMBIA CANCER AGENCY BRANCH 2 Vancouver, BC Canada
The University of British Columbia 2 , Canada
The University of Biritish Columbia 1 Vancouver, Canada
The University of British Columbia 1 Vancouver, BC Canada
UNIVERSITY OF BRITISH COLUMBIA 1 Vancouver, Canada
THE UNIVERSITY OF BRITISH COLUMBIA UNIVERSITY-INDUSTRY LIAISON OFFICE 1 Vancouver, BC Canada

Recent patent applications by Andersen Raymond John

Raymond John Andersen from Vancouver, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-27

US20250100986A1

Chemistry; metallurgy

BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS

#2 | 2024-11-28

US20240391883A1

Chemistry; metallurgy

HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE

#3 | 2023-06-08

US20230174571A1

Chemistry; metallurgy

METHOD OF TREATING SHIP1-MEDIATED DISEASES USING PELOROL DERIVATIVES

#4 | 2023-03-16

US20230078913A1

Human necessities

ANDROGEN RECEPTOR MODULATORS AND METHODS FOR USE AS PROTEOLYSIS TARGETING CHIMERA LIGANDS

#5 | 2022-12-01

US20220380325A1

Chemistry; metallurgy

ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE

#6 | 2022-08-25

US20220267283A1

Chemistry; metallurgy

HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE

#7 | 2022-07-14

US20220218632A1

Human necessities

Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof

#8 | 2021-07-01

US20210198213A1

Chemistry; metallurgy

Androgen receptor modulators and methods for their use

#9 | 2021-04-08

US20210100757A1

Human necessities

Bisphenol ether derivatives and methods for using the same

#10 | 2020-10-15

US20200325106A1

Chemistry; metallurgy

Heterocyclic compounds for cancer imaging and treatment and methods for their use

#11 | 2020-08-06

US20200247763A1

Chemistry; metallurgy

Androgen receptor modulators and methods for their use

#12 | 2020-07-02

US20200206155A1

Human necessities

BISPHENOL ETHER DERIVATIVES AND METHODS FOR USING THE SAME

#13 | 2018-11-15

US20180327368A1

Chemistry; metallurgy

Heterocyclic compounds for cancer imaging and treatment and methods for their use

#14 | 2018-08-23

US20180235925A1

Human necessities

BISPHENOL COMPOUNDS AND METHODS FOR THEIR USE

#15 | 2018-03-08

US20180064657A1

Human necessities

Bisphenol ether derivatives and methods for using the same

#16 | 2017-05-04

US20170121261A1

Chemistry; metallurgy

DIGLYCIDIC ETHER DERIVATIVE THERAPEUTICS AND METHODS FOR THEIR USE

#17 | 2016-12-22

US20160367707A1

Human necessities

HALOGENATED COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE

#18 | 2015-05-07

US20150125389A1

Human necessities

Halogenated compounds for cancer imaging and treatment and methods for their use

#19 | 2015-01-08

US20150010469A1

Chemistry; metallurgy

BISPHENOL ETHER COMPOUNDS WITH NOVEL BRIDGING GROUPS AND METHODS FOR THEIR USE

#20 | 2014-09-04

US20140248263A1

Human necessities

BISPHENOL COMPOUNDS AND METHODS FOR THEIR USE

#21 | 2013-12-19

US20130336962A1

Chemistry; metallurgy

Aziridine bisphenol ethers and related compounds and methods for their use

#22 | 2013-02-21

US20130045204A1

Chemistry; metallurgy

FLUORINATED BISPHENOL ETHER COMPOUNDS AND METHODS FOR THEIR USE

InventorID:

100304 ⎘